Hisakazu Degawa Selected Research

Symporters

3/2022	Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists.
1/2019	Retrospective analysis of effects of sodium-glucose co-transporter 2 inhibitor in Japanese type 2 diabetes mellitus patients with chronic kidney disease.
1/2019	Renal effects of sodium glucose co-transporter 2 inhibitors in Japanese type 2 diabetes mellitus patients with home blood pressure monitoring.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hisakazu Degawa Research Topics

Disease

4	Type 2 Diabetes Mellitus (MODY) 03/2022 - 01/2019
4	Chronic Renal Insufficiency 01/2021 - 01/2019
2	Hypertension (High Blood Pressure) 01/2022 - 01/2019
1	COVID-19 01/2022
1	Infections 01/2022
1	Diabetes Mellitus 01/2021
1	Masked Hypertension 01/2019
1	White Coat Hypertension 01/2019
1	Anemia 12/2008

Drug/Important Bio-Agent (IBA)

4	SodiumIBA 03/2022 - 01/2019
4	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 01/2019
3	SymportersIBA 03/2022 - 01/2019
3	Sodium-Glucose Transport ProteinsIBA 01/2021 - 01/2019
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019
1	Pharmaceutical PreparationsIBA 12/2008
1	Hemoglobins (Hemoglobin)IBA 12/2008
1	epoetin betaIBA 12/2008

Therapy/Procedure

1	Therapeutics 01/2019
1	Intravenous Administration 12/2008
1	Renal Dialysis (Hemodialysis) 12/2008